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Specialty Update
What’s New in Spine Surgery
By Keith H. Bridwell, MD, Paul A. Anderson, MD, Scott D. Boden, MD, Alexander R. Vaccaro, MD, and Jeffrey C. Wang, MD
What’s New in the Treatment of the Cervical Spine
Trends in the treatment of the cervical spine include the
evaluation of new technology as well as a focus on the un-
derstanding of old concepts and postulates. The results of
randomized controlled trials of cervical arthroplasty are now
available, and this procedure appears promising.
Anatomy
To safely perform many of the complex surgical procedures
that involve the use of screw fixation, an understanding of the
surgical anatomy of the cervical spine is essential. Osseous
and vascular anomalies in the cervical spine that place the
vertebral artery at risk during surgery have been identified.
The vertebral artery normally enters the spine at C6 and as-
cends in the foramen transversarium until C2, where it turns,
first laterally and then cranially, and ascends into the C1 fo-
ramen transversarium. It then loops medially, lying on the
superior surface of the C1 arch. Approximately 15 mm from
the midline, it turns anteriorly, enters the spinal canal, and
passes through the foramen magnum. In the subaxial spine in
a small number of patients, the artery can enter at C7 (or,
more commonly, it can become ectatic with age) and can
intrude into the vertebral body, placing it at risk during
corpectomy. This finding is easily recognized on anteropos-
terior radiographs or axial computed tomography and mag-
netic resonance images. The vertebral artery may pass too far
rostrally and medially within C2, thinning the pedicle so that
C1-C2 transarticular and C2 pedicle screws cannot be placed
safely. This occurs in as many as 15% of cases. As an alter-
native, screw purchase can be obtained in the C2 lamina,
thereby avoiding vertebral artery risk. Biomechanical studies
comparing this method with other C2 screw constructs have
shown similar fixation strength.
Lateral mass fixation into C1 is gaining popularity. Screw
position is critical, as rostrally angled screws can penetrate the
atlanto-occipital articulation and screws that extend too far
anteriorly may injure the carotid artery. Because the anterior
arch of the atlas is 3 to 5 mm more anterior than its lateral
masses, screws may easily extend anteriorly even though they
appear to be in an appropriate position. The internal branch of
the carotid artery can lie directly anterior to the C1 lateral mass
and may be damaged. The ponticulus posticus is an osseous
bridge over the craniolateral aspect of C1 that encloses the
vertebral artery. It occurs in as many as 19% of patients. One
method of C1 lateral mass screw placement is to place screws
into the posterior C1 arch (if large); this should be avoided
when a ponticulus posticus is present. Other important anom-
alies include a fenestrated vertebral artery and a takeoff of the
posterior inferior cerebellar artery between C1 and C2, which
is present in 0.5% of the Korean population. Many of these
anomalies can be predicted on the basis of minor osseous
radiographic changes at C1, such as asymmetry, scalloping, or
widening of the foramen transversarium. When present,
computed tomography angiography or magnetic resonance
angiography is recommended prior to screw placement.
Myelopathy
Early physical findings of myelopathy classically include
clumsiness and hypesthesia of the hands, ataxic gait, hyper-
reflexia, and pathologic reflexes such as clonus, the Hoffmann
sign, and the Babinski sign. Rhee found that in patients having
a successful outcome following decompression for myelopathy
that a pathologic finding was present in only 78% of patients
preoperatively. Surprisingly, the prevalence of hyperreflexia
was no different from the prevalence in individuals without
myelopathy. Sustained clonus and Babinski signs were present
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in only one-third of the patients with myelopathy. The Hoff-
mann sign was the most common finding, occurring in
roughly 80% of myelopathic patients, and it was more com-
mon with increasing severity of the myelopathy. These findings
are difficult to quantify and may be present normally or may
result from other diseases. More quantitative means for the
assessment of myelopathic patients are the ten-second stepping
test (the number of steps that a patient can perform in ten
seconds while standing in place) and the finger grip and release
test. Normal patients can perform more than twenty repeti-
tions of each test, whereas myelopathic patients perform fewer
than fifteen grip and eleven stepping functions.
Disc Arthroplasty
Three cervical disc arthroplasty devices have been approved by
the United States Food and Drug Administration (FDA) panel
for implantation into patients with single-level radiculopathy
or myelopathy who have had a failure of nonoperative man-
agement. Exclusion criteria include severe spondylosis, insta-
bility, facet joint arthrosis, and congenital spinal stenosis.
Approval was gained on the basis of three randomized con-
trolled studies that were designed to show that arthroplasty is
equivalent to arthrodesis with use of an allograft and plate. The
outcomes were assessed at two years, with the primary out-
come variables being improvement in terms of neck disability
and overall clinical success. All three studies demonstrated that
arthroplasty is equivalent to arthrodesis, with the benefit of
maintenance of intervertebral motion. The adverse outcomes
were no different from those in controls. Many of the sec-
ondary variables showed significantly favorable results in as-
sociation with arthroplasty, such as earlier return to work,
greater improvement in functional outcomes, and lower re-
operation rates. Other subgroup analyses have shown the ef-
ficacy of both arthrodesis and arthroplasty for the treatment of
myelopathy at a single level and in patients receiving Workers’
Compensation. The early results of those investigations are
reassuring, but long-term follow-up is needed to determine the
ultimate role of cervical arthroplasty.
Epidural Steroid Injections
Steroid injections performed by means of either an intra-
laminar or a transforaminal route are routinely prescribed for
patients with radiculopathy and myelopathy. Rare cases of
spinal cord infarction and quadriplegia have been reported
following cervical steroid injection. The mechanism is thought
to be intra-arterial injection into the radicular artery and/or
vasospasm. The radicular artery arises from the vertebral ar-
tery and is located along the ventral root surface. It gives rise to
a medullary artery, which joins the anterior spinal artery and,
in some cases, a posterior branch supplying the dorsal root
ganglion. Cannulation of this branch is possible and may lead
to a direct intramedullary injection of medication. Injectable
particulate (Depo-Medrol) and nonparticulate (Decadron)
corticosteroids are available. Direct injection of particulate
steroid into the vertebral arteries of pigs resulted in stroke,
whereas injection of nonparticulate medication had no effect.
These data suggest that cervical injections should be done with
radiographic confirmation that intravascular needle position-
ing has not occurred, and they also suggest that nonparticulate
steroids may be safer.
What’s New in Biologic Topics Related to the Spine
Spine remains at the forefront of advances in biologics as an
application to musculoskeletal disorders. Efforts continue to
enhance the process of achieving spine fusion and to eliminate
the need for autogenous iliac crest bone graft harvest. Since the
FDA’s postmarketing approval of rhBMP-2 in 2002 and Hu-
manitarian Device Exemption for rhBMP-7 late in 2004, the
use of recombinant bone morphogenetic proteins (BMPs) in
spine fusion continues to grow. Given the limited access to
recombinant proteins (with only two companies having ap-
proved BMPs) as well as their relatively high cost, there has
been renewed interest in promoting less expensive and poorly
validated alternatives. In addition, while research continues to
focus on developing biologic strategies to retard or reverse
intervertebral disc degeneration, these treatments remain years
away from clinical practice.
Recombinant Osteoinductive Proteins
The initial clinical studies of rhBMP-7 (OP-1, Stryker Biotech,
Hopkinton, Massachusetts) for posterolateral spine fusion
yielded rates of successful radiographic fusion of 50% to 70%,
and these modest fusion rates were attributed to the use of a
‘‘more challenging’’ noninstrumented spine fusion model.
Data last year on surgical fusion showed a fusion success rate of
approximately 50% in association with OP-1 when used for
instrumented fusion, still not at a level consistently equal or
superior to that associated with autograft. Data from the
United States trial on the use of OP-1 for posterolateral fusion
remain under review by the FDA for consideration for post-
marketing approval. Only one spine study involving the use of
OP-1 in addition to iliac crest autograft was published in 2007.
The study involved thirty patients with cervical or lumbar
pseudarthrosis. The rate of successful fusion on plain radio-
graphs was 80%. With that study design, it was hard to discern
whether OP-1 had a greater effect than iliac crest bone graft
did.
Although rhBMP-2 (INFUSE; Medtronic Sofamor
Danek, Memphis, Tennessee) has been approved by the FDA
for anterior lumbar interbody fusion, considerable physician-
directed use has occurred in the posterolateral spine. Glassman
et al. reported on ninety-one patients who received 12 mg of
INFUSE in a sponge wrapped around a bulking agent (local
bone, allograft, hydroxyapatite/tricalcium phosphate granules,
or demineralized bone matrix). In that series, 93% of the pa-
tients had radiographic fusion on thin-slice computed to-
mography scans. Although the difference was not significant,
the local bone or allograft chips appeared to be the better
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bulking agents. In another study, the same authors reported on
a higher concentration of rhBMP-2 (2.0 mg/mL), not yet
clinically available, and demonstrated that this concentration
achieved 100% computed tomography-based fusion success in
95% of a subgroup of patients who were smokers. Those two
studies highlight a consistent trend of very high fusion rates in
association with rhBMP-2. Perhaps someday the combination
of rhBMP-2 with another agent such as the prostaglandin EP4
receptor agonist will allow the use of lower BMP doses. An-
other potential strategy that has been validated only at the
rodent level is combining the natural BMPs found in demin-
eralized bone matrix with a synergistic agent such as Nell-1 to
improve the performance of the demineralized bone matrix.
A primary concern associated with the off-label use of
recombinant BMPs is related to local adverse events. The three
most commonly reported local side effects have been hetero-
topic bone formation in the surgical approach track, transient
bone resorption when used near exposed cancellous bone, and
sterile seroma fluid collections and/or local edema. Most of
these local side effects are believed to be related to the use of
more BMP as a result of either an increased concentration of
the growth factor on the sponge or overstuffing of the defect
with more sponge than is recommended. In the cervical spine,
one report cited a twofold increase in the prevalence of
moderate or severe dysphagia following the use of rhBMP-2.
The true prevalence of this complication seems technique-
related and manageable with systemic steroids.
INFUSE is also being used widely for lumbar trans-
foraminal and posterior interbody fusions. In a pilot inves-
tigational device exemption study that was suspended, the
authors noted some ectopic bone formation on the ventral
aspect of the spinal canal related to cage prominence and
reported that the finding did not correlate with an adverse
clinical outcome. Wong reported the cases of five such pa-
tients who had neurologic impairment resulting from the
ectopic bone, challenging the previous position that ectopic
bone formation did not result in neurologic findings. An-
other study demonstrated vertebral osteolysis in five of sixty-
eight patients within four months after transforaminal
lumbar interbody fusion with rhBMP-2. In all five cases,
the osteolysis was transient and symptoms and radiographic
findings improved by six months postoperatively. A study by
the North American Spine Society demonstrated a higher-
than-expected prevalence of radiculitis two years after
INFUSE usage, and this side effect will need to be closely
monitored to better define its prevalence and to identify
preventive strategies that are effective.
While the actual rate of INFUSE-related complications is
difficult to pinpoint, fewer than 400 adverse events have been
reported to Medtronic after the use of an estimated 500,000
kits of INFUSE since 2002. Certainly, there is likely to be an
underreporting phenomenon, especially for the three already
known local side effects. Still, the incidence of severe side ef-
fects seems to be very low and potentially may be lowered
further by dissemination of techniques for safe use as more
physician-directed studies are published.
Other Bone-Graft Substitutes
Although much focus remains on recombinant osteoinductive
proteins, their relatively high cost continues to drive research
involving other bone-graft solutions with simpler regulatory
hurdles. Yet another study demonstrating the failure of platelet
concentrates to improve spine fusion healing was published
this year. That study adds to a growing body of literature
suggesting that platelet gels either inhibit or have no effect on
spine fusion healing. While platelet gels may be useful for
impaired wound-healing and possibly for diabetic foot surgery
bone-grafting, their role in promoting bone formation in the
spine remains highly unsubstantiated.
Demineralized bone matrix is now regulated by the FDA,
resulting in a small increase in efficacy data for some formu-
lations. However, clinical data are still quite sparse. Schizas, in
a pilot clinical study of fifty-nine patients undergoing postero-
lateral lumbar spine fusion with instrumentation, recently
reported that one type of demineralized bone matrix (Accell
Connexus; IsoTis OrthoBiologics, Irvine, California) was as-
sociated with a radiographic fusion success rate (70%) that was
comparable with that of iliac crest bone or local bone alone
(77%). The questionable sensitivity of plain radiographs to
detect nonunion in the presence of internal fixation is a
weakness of that and many similar studies.
Interest in mesenchymal stem cells remains high but,
because most of these products are regulated as ‘‘minimally
manipulated tissues,’’ few outcome data from rigorously de-
signed studies are likely to be available in the near future. The
studies that are under way may not include the proper controls
to assess whether the stem cells are providing any increased
healing in comparison with the allograft alone. These and
other minimally manipulated products that are claimed to
have bone-healing potential must be carefully evaluated by
surgeons as the FDA does not require definitive proof of bone-
enhancing capability.
Biologic Treatments for Disc Degeneration
Progress toward biologic treatments to prevent or retard disc
degeneration has continued at a slow pace. Continued animal
evidence of beneficial effects of recombinant BMPs (BMP-7,
BMP-2, GDF-5) on disc metabolism have prompted the
planning of a clinical trial to investigate the response in hu-
mans. A majority of this preclinical work has been performed
with OP-1, which can prevent disc height loss after needle
puncture injury or chondroitinase administration. Recent ev-
idence of the presence of skeletal progenitor cells in degen-
erated human intervertebral disc material suggests that growth
factor-driven therapy may not necessarily require the addition
of exogenous cells. One study demonstrated preliminary re-
sults in association with the use of platelet-rich plasma and
biodegradable gelatin hydrogel microspheres to retard injury-
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induced disc degeneration in rabbits. An interim report on a
small pilot clinical trial in which autologous disc chondrocytes
were injected twelve weeks after lumbar discectomy showed
that the patients who had received chondrocyte injections had
less low back pain than controls did at two years. These bio-
logic disc solutions, which likely will have complex regulatory
hurdles, will need to outperform more simplistic tissue-
engineered solutions involving the injection of cross-linked
scaffolds and polymers.
What’s New in Spinal Deformity Surgery
This past year, attendance records were broken for the Scoliosis
Research Society (SRS) annual meeting in Edinburgh, Scot-
land, and the International Meeting on Advanced Spine
Techniques (IMAST) in the Bahamas. We are all still very
saddened by the passing of Thomas Lowe, MD, who was to be
President of the SRS for 2007 to 2008. His leadership is sorely
missed.
Idiopathic Scoliosis
The ideal surgical treatment for false double-major curves
continues to evolve. There are data to suggest that treating
thoracic curves anteriorly results in more of a true spontane-
ous correction of the lumbar curve, but there is more mor-
bidity in association with an anterior surgical approach than
there is in association with a posterior surgical approach. The
outcomes are better if the thoracic spine is selectively fused as
opposed to fusing well into the lumbar spine or fusing both
curves.
The use of thoracic pedicle screws results in potentially
more correction than can be achieved with hooks and wires or
with a hybrid construct of hooks and screws. It is debatable
whether a 55% or 65% correction is of any clinical importance,
but if the pedicle screw technique can allow the surgeon to
avoid an anterior operation or save distal fusion segments,
there is a substantial benefit. There is still concern that thoracic
pedicle screws carry more risk than wires or hooks do, but to
date no reports have suggested the thoracic screw technique is
associated with a higher rate of neurologic deficit. Another
complication unique to pedicle screws is the risk to the great
vessels.
The most widely used clinical outcome measure for id-
iopathic scoliosis is the SRS patient-assessment questionnaire.
This is variably used with either twenty-two, twenty-four, or
thirty questions. For a high percentage of adolescent patients,
the instrument does not demonstrate a substantial improve-
ment. In fact, one study suggested that patients with idiopathic
scoliosis reported more pain at five years than at two years after
surgical treatment.
Measures to assess the patient’s skeletal maturity con-
tinue to generate substantial interest. There is increasing in-
terest in the assessment of the triradiate cartilage on a pelvic
radiograph and the wrist, fingers, and metacarpals on a hand
radiograph, and now there is interest in using the olecranon to
assess the proximity to skeletal maturity and the end of peak
growth velocity.
Adult Spinal Deformity
How to reduce the pseudarthrosis rate with a long fusion in the
adult patient and how to achieve a solid fusion at L5-S1 con-
tinue to generate research. The role of iliac screws or a second
pair of sacral screws and anterior column support at L5-S1 is a
topic of interest. Also, analysis of the decision of whether to
stop a long fusion at L5 or S1 continues to evolve. The answer
to stopping at L5 or S1 is difficult to study without prospective
multicenter randomization and five to ten years of follow-up.
The use of biologics for the treatment of deformity in
adults is becoming more widespread, although very few data
have been published. However, difficulties with studying the
use of bone morphogenetic proteins for the treatment of spinal
deformities in adults include the high expense associated with
the use of a substantial dose and the difficulty of assessing a
multilevel fusion with use of radiographs.
Improvement and/or maintenance of sagittal balance in
an adult patient with a spinal deformity remains a substantial
challenge. Predicting the ideal balance is quite difficult. It is
somewhat dependent on the thoracic kyphosis, the pelvic in-
cidence, and the number of levels being fused. A percentage of
patients who have fusion of only the lumbar curve will sub-
sequently decompensate because of progressive kyphosis of the
thoracic spine.
There is evolving evidence that the SRS instrument is
quite responsive to change brought on by the operative treat-
ment of deformity in the adult population. This is in distinct
contrast to the findings in the adolescent population. However,
there are no current data to assess whether or not the instru-
ment is responsive to nonoperative treatment of spinal de-
formity in the adult patient.
Severe Deformities
The use of pedicle screw implants facilitates the treatment of
severe deformity, defined as a scoliosis curve of >100 or a
sagittal kyphosis of >120. In addition, halo-gravity and halo-
femoral traction may have a role and vertebral column resec-
tion is an option for these severe deformities. One report at the
recent SRS meeting in Edinburgh suggested that resection
procedures could be performed with a more acceptable
amount of blood loss with use of an antifibrinolytic, such as
aprotinin. Unfortunately, aprotinin is no longer available. Al-
though anterior release has been considered a necessary and
helpful ingredient in the correction of large curves, there is
currently a strong trend away from it and toward more reliance
on posterior release (osteotomy and spinal shortening)
techniques.
Congenital Spinal Deformity
Resection of the hemivertebra in cases of failure of formation
continues to be regarded as a valuable and safe operation in a
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young patient. Answers to the question of whether resection
should be performed through an all-posterior approach,
separate anterior and posterior approaches, or perhaps an
anterior-only approach continue to evolve. When a patient has
a unilateral failure of vertebral segmentation, the prognosis
and natural history are not entirely predictable. Patients with
multiple failures of formation and segmentation in the tho-
racic spine are at risk for thoracic insufficiency syndrome.
Addressing the deformity with primary spinal or rib-cage
lengthening still has no clear answer, although rib-cage
lengthening is currently generating more attention.
Neuromuscular Scoliosis
The use of corticosteroid treatment for Duchenne muscular
dystrophy has reduced the need for surgical treatment of the
associated spinal deformity. The effect of correction of the
spinal deformity on respiratory function remains difficult to
quantitate. There is evolving evidence that the use of an anti-
fibrinolytic agent during neuromuscular scoliosis surgery can
significantly decrease operative blood loss. For some of these
patients, particularly those with cerebral palsy, spinal cord
monitoring is challenging, and there may be a benefit associ-
ated with the use of transcranial motors. For a patient with
cerebral palsy, it appears that a preexistent baclofen pump will
increase the risk of complications if deformity fusion is sub-
sequently performed.
Spondylolisthesis
There is no clear indication for when to reduce a high-grade
spondylolisthesis as opposed to performing a fusion with mild
correction of the slip angle. Factors associated with ideal sag-
ittal balance and the risk of deformity progression in a young
patient are being extensively researched, and a classification
system is being studied in a multicenter fashion. Consider-
ations include dysplasia of the L5 lamina, the extent and nature
of the remodeling of the sacral dome, and the pelvic incidence.
What’s New in Spinal Cord Injury
Over the last year, researchers have continued to study the
basic science and clinical aspects of spinal cord injury. Of
particular note, there has been an increased focus on quality
evidence-based research and the development and validation
of outcome measures that facilitate evidence-based outcomes
research.
Outcome Measures
The availability of quality outcome measures of the various
aspects of spinal cord injury is essential to the advancement of
this research. With this in mind, the SCI Meeting Measures
Group convened in 2006 to discuss outcome measures in
several key areas. Select peer-reviewed proceedings from this
meeting were published in The Journal of Spinal Cord Medicine
in 2007. One of these articles was an evidence-based literature
review on the use of neuroimaging in the setting of acute spinal
cord injury. The goal of that review was to provide clinicians
and researchers with recommendations and guidelines for the
use of neuroimaging modalities to assess spinal cord injury.
The authors reviewed 2300 published reports on the use of
neuroimaging for the evaluation of spinal cord injury, ninety-
nine of which were either clinical studies (sixty-nine), pre-
clinical studies (twenty-three), or review articles (seven) in
which neuroimaging was a key component of the outcome
measure (or measures). On the basis of their systematic
review of the literature, the authors made a number of rec-
ommendations and comments: (1) magnetic resonance
imaging remains the test of choice for locating the level of a
spinal cord injury and assessing the amount of compression on
the spinal cord, (2) the severity of cord injury on magnetic
resonance imaging (i.e., evidence of cord edema, contusion,
hemorrhage, and disruption) correlates with the degree of
motor and sensory impairment and is helpful for determining
the prognosis for neurological recovery, (3) diffusion-weighted
magnetic resonance imaging can detect axonal integrity and
swelling and can be used to quantify the amount of axonal loss
following spinal cord injury, (4) functional magnetic reso-
nance imaging can detect motor and sensory activity in the
injured spinal cord, and (5) plain radiographs and computed
tomography scans should be used to evaluate osseous injury
but do not provide useful information regarding the injured
spinal cord.
While discussing imaging, it is important to note that a
novel classification system for injuries of the subaxial cervical
spine, referred to as the Subaxial Injury Classification (SLIC)
and Severity Scale, was recently developed by the Spine Trauma
Study Group. In this system, injuries are classified according to
three main categories: (1) the injury morphology as deter-
mined on the basis of plain radiographs, computed tomogra-
phy, and magnetic resonance imaging; (2) the integrity of the
discoligamentous complex, which consists of the intervertebral
disc, anterior and posterior longitudinal ligaments, ligamen-
tum flavum, interspinous and supraspinous ligaments, and
facet capsules; and (3) the neurological status of the patient.
The three main morphologies include compression, distrac-
tion, and translation/rotation. The discoligamentous complex
is categorized as intact, disrupted, or indeterminate. The in-
tegrity of the discoligamentous complex is best assessed by
using all available imaging studies to look for evidence of a
widened space between the spinous processes, disc-space
widening, vertebral subluxation, and subluxation or disloca-
tion of the facet joints. The neurologic status of the patient is
described as intact, nerve-root injury, complete, or incomplete.
A point system is used to quantify the injury of the cervical
spine and to help to guide treatment. This system has been
shown to have moderate to substantial intraobserver and in-
terobserver reliability and excellent construct validity (>90%).
It is hoped that this classification system will improve com-
munication and facilitate quality research regarding injury of
the cervical spine.
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Pain is one of the most common and debilitating
problems encountered in patients with a spinal cord injury. A
study presented at the 2007 annual American Spinal Injury
Association (ASIA) meeting evaluated chronic pain in thirty
patients who had sustained a spinal cord injury more than one
year previously and highlighted the overwhelming need to
improve pain management both during post-injury rehabili-
tation and after transition into the community. For both
clinical and research purposes, therefore, it is important to be
able to reliably measure pain in these patients. A recent sys-
tematic review of the literature evaluated the reliability and
validity of outcomes measures for pain following spinal cord
injury. On the basis of their review, the authors found that the
numeric rating scale (0 to 10 points) was the most reliable for
assessing pain intensity in patients with spinal cord injury. The
7-point Patient Global Assessment of Change (PGAC) scale
was the best measure for the evaluation of global improvement
in terms of pain. The authors recommended the use of either
the International Association for the Study of Pain (IASP) or
the Bryce/Ragnarsson SCI pain taxonomies when classifying
pain in patients with a spinal cord injury.
Numerous rating scales that address general health,
function, and quality of life have been developed and refined
over the last several years, with a considerable amount of re-
dundancy. Despite these efforts, no single scale has been widely
accepted in spinal cord injury research. Work is currently
under way to develop reliable and valid outcome measures of
general health, function, and quality of life that are tailored
specifically to patients with spinal cord injury.
Clinical Outcome Studies
Many of the clinical outcome studies of patients with spinal
cord injury that were presented at the 2007 annual ASIA
meeting evaluated psychosocial and quality-of-life issues. In
one study, patients who returned to work following a spinal
cord injury were compared with those who did not return to
work following such an injury. Only 21% of patients returned
to work within three years after the post-injury rehabilitation.
Most of the patients who returned to work had a college-level
education and had worked in a nonmanual labor setting before
the injury. That study emphasized the importance of coun-
seling patients who have a lower level of education and/or who
worked in a manual labor setting. Another study evaluated
long-term life satisfaction among 251 adults who had sus-
tained a spinal cord injury during childhood or adolescence.
Satisfaction was significantly higher among women, those who
were married, and those who were employed. Satisfaction was
significantly lower among those who used illicit drugs, those
who had been injured at an older age, those who lived with
their parents, and those who had pressure sores during the last
year. These findings can be helpful for guiding rehabilitation
and counseling strategies for patients who sustain a spinal cord
injury at a young age. A similar study evaluated the educational
achievements of 350 adults who had sustained a spinal cord
injury at a young age. For individuals with quadriplegia as well
as those with paraplegia, a higher level of education was sig-
nificantly associated with greater employment, income, and
community participation. These findings further emphasize
the importance of education with regard to quality of life
following a spinal cord injury. In a study that evaluated the
association of walking and independence with health, partic-
ipation, and subjective well-being outcomes following spinal
cord injury, independence in mobility was surprisingly asso-
ciated with significantly better outcomes than was the ability to
walk.
Emerging Therapies
Post-injury therapy is one of the most important aspects of
care for patients who have sustained a spinal cord injury.
Various therapy strategies to maintain and potentially regain
strength, flexibility, and the ability to walk have been described
in the past. Locomotive training (also known as body weight-
supported treadmill training or suspended treadmill training)
has recently received considerable attention in the literature.
This form of therapy involves harness suspension of the patient
over a moving treadmill in order to provide the repetitive
sensory experience of walking. The theory is that this sensory
stimulation can facilitate recovery of motor function that may
improve walking ability in patients with an incomplete spinal
cord injury. A neural network within the spinal cord, which, in
itself, is capable of producing rhythmic motor-patterned out-
puts (i.e., the human locomotion spinal pattern generator), is
thought to be responsible for the improved walking function
achieved through locomotive training.
Several studies presented at the 2007 annual ASIA
meeting evaluated various aspects of locomotive training.
A feasibility study of twenty-eight patients who underwent
locomotive training following a spinal cord injury demon-
strated, on the basis of reimbursement rates and actual costs,
that this type of therapy was a fiscally feasible form of
treatment despite the personnel and resources required.
Studies also demonstrated the clinical success of this type of
therapy. A recent case report documented the restoration of
walking ability in a four and one-half-year-old child follow-
ing a severe spinal cord injury that resulted in a C8-level ASIA
C injury. After seventy-six sessions of locomotive therapy, the
patient was able to walk as many as 2400 steps per day with a
rolling walker, despite a persistent inability to voluntarily
activate lower extremity movements. That case report sup-
ports the presence of a human locomotion spinal pattern
generator, which, with appropriate sensory stimulation, can
initiate the rhythmic, patterned movement necessary for
walking. Twenty-four patients with an incomplete motor
spinal cord injury who had the ability to generate a rhythmic
stepping pattern were studied. Those patients showed a sig-
nificant recovery of walking function during six-minute and
10-m walking tests following a standardized locomotive
training program.
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Neuroprotective Treatments
Efforts to develop pharmacological, biological, and physio-
logical means to prevent secondary spinal cord injury and to
improve the recovery of function following spinal cord injury
continue to be evaluated. Although high-dose methylpred-
nisolone continues to be routinely administered at many spinal
cord injury centers according to the accepted protocols, its use
remains controversial because of the lack of clinical data to
support its efficacy and the associated complications that have
been reported. Many of the preclinical results of stem-cell and
immune-based therapies for spinal cord injury are promising.
Large, multicenter clinical trials are necessary, however, to
determine the efficacy of these interventions for the treatment
of spinal cord injury in humans. Following the spinal cord
injury sustained by the Buffalo Bills’ tight end Kevin Everett
during a National Football League game, therapeutic hypo-
thermia for the treatment of acute spinal cord injury has re-
ceived much attention in the public media. Theoretically, by
giving an intravenous infusion of cold fluid and inducing a
moderate hypothermia, this treatment minimizes the swelling
and secondary injury of the spinal cord and facilitates func-
tional recovery. There is currently no standardized protocol for
this therapy in terms of its induction, the degree of hypo-
thermia, or duration. Although preclinical animal studies of
therapeutic hypothermia have shown some evidence of suc-
cess, clinical data do not support its efficacy, and the clinical
application of therapeutic hypothermia is not currently rec-
ommended for routine use in patients who have sustained a
spinal cord injury.
What’s New in the Treatment of the Lumbar Spine
Disorders of the lumbar spine continue to present some of the
most common and clinically important problems faced by a
large percentage of the population. Recent studies have high-
lighted research into a better understanding of the pathogen-
esis of the degenerative process, and novel technologies
designed to treat such pathology continue to proliferate. Fur-
thermore, longer-term results have demonstrated the efficacy
of some of these approaches.
Outcomes
Lumbar total disc arthroplasty has been a very controversial
topic over the past few years, with several studies demon-
strating equivalence to spinal fusion. A recent multicenter
study examining the Maverick prosthesis showed that lumbar
total disc arthroplasty was superior to fusion with regard to key
clinical outcomes scores, back pain scores, patient satisfaction,
and earlier return to work. Additional studies may need to
demonstrate more than equivalence to fusion in terms of pa-
tient outcomes scores in order for this procedure to gain more
sustained clinical acceptance.
Because of the challenges with defining success after
spinal surgery, spine surgeons from Stanford University pre-
sented their model for minimum acceptable outcomes after
surgery. That study focused on establishing the validity of
patient-determined minimum acceptable outcomes as a cri-
terion of surgical success rather than using the typical arbitrary
benchmarks of patient measurement scales, which may not
equate to clinical improvement. That study examined and
proposed new criteria for assessment following spinal surgery,
and it was thought to be more reflective of global success,
which may not be measurable by functional improvement,
earlier return to work, or a decrease in pain medications.
Certainly, that study is making spine practitioners reconsider
outcomes measurements.
Growth Factors for Spinal Fusion
The use of growth factors instead of autogenous bone graft for
lumbar fusion is increasing, especially the use of BMPs. The
off-label usage appears to be increasing, and several studies
with longer-term results were presented this past year.
The use of BMP-2 for transforaminal lumbar interbody
fusion was shown to be associated with increased postoper-
ative radiculitis. The authors presented the results of a study
in which thirty-nine patients who were managed with BMP
were compared with a control group of twenty-nine patients
who were managed with autogenous iliac crest bone graft.
The two groups were very similar, but the prevalence of
postoperative radiculitis was significantly greater in the BMP
group than in the control group (23% compared with 3%).
The average duration of these symptoms was more than
thirteen months, which can present some clinically impor-
tant issues.
Another study from St. Louis examined a group of
ninety-two patients who were managed with repeat use of
BMP-2 in the spine after having had a previous spinal fusion
with BMP-2. There is always a theoretical concern regarding
the repeat exposure of patients to BMPs, with the possibility of
antibody formation and a hypersensitivity response. In that
retrospective study, there was not a clinically important effect
of repeated exposure to BMP-2 as compared with the findings
in a control group, and there did not appear to be any issue
with safety or efficacy, regardless of the timing of the second
dose.
A prospective multicenter study investigated the use of
BMP-2 with a collagen sponge wrapped around ceramic
granules as a bulking agent for lumbar posterolateral fusion
compared with a control group with autogenous iliac crest
bone graft. For this off-label usage, twenty-five patients
were managed with the BMP-2, whereas twenty-one were in
the control group. There were no adverse events, and the
fusion rate in the BMP-2 group was higher than that in the
control group (81% compared with 60%). The outcomes
measures all favored the BMP-2 group over the control
group.
A group of investigators from Los Angeles reported on
the use of a bone morphogenetic binding protein (BBP)
combined with BMP-2 for spinal fusion. This protein appears
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to bind and retain the BMP in the surgical site and also po-
tentiates the osteogenic ability of the BMPs. That animal study
showed that BBP combined with a low dose of BMP-2 had
additive effects and significantly increased the fusion rates in
comparison with BMP-2 alone. This may allow the use of
decreased BMP-2 dosages in humans in the future and hence
potentially decrease side effects.
Complications
Anterior retroperitoneal approaches to the lumbar spine are
associated with sexual dysfunction in men. One group studied
this problem in women. That study, which included thirty
women who were managed with an anterior retroperitoneal
approach, demonstrated a 6.7% prevalence of postoperative
sexual dysfunction; however, the dysfunction appeared to be
well tolerated.
Another group examined the overall rate of vascular
complications following procedures performed with and
without the involvement of a vascular access surgeon. Overall,
they found that 6% of patients had an intraoperative vascular
complication, but there was no significant difference between
procedures in which the approach had been performed by a
vascular access surgeon and those in which it had been per-
formed by the spine surgeon. The investigators concluded that
there was no need to mandate the use of a vascular access
surgeon if the spine surgeon was sufficiently trained to per-
form the approach.
Evidence-Based Orthopaedics
The editorial staff of The Journal reviewed a large number of
recently published research studies related to the musculo-
skeletal system that received a Level of Evidence grade of I.
Over 100 medical journals were reviewed to identify these
articles, all of which have high-quality study design. In addi-
tion to articles published previously in this journal or cited
already in this Update, nineteen additional level-I articles were
identified that were relevant to spine surgery. A list of those
titles is appended to this review following the standard bibli-
ography. We have provided a brief commentary about each
of the articles to help to guide your further reading, in an
evidence-based fashion, in this subspecialty area.
Upcoming Meetings and Events Related to Spine
Surgery
The forty-third Annual Meeting of the Scoliosis Research
Society (SRS) will be held on September 10 through 13,
2008, at the Grand America Hotel in Salt Lake City, Utah.
It will be preceded by a one-day course entitled ‘‘Osteo-
biologics,’’ to be held on September 8, 2008. Web site:
www.srs.org
The twenty-third Annual Meeting of the North Ameri-
can Spine Society (NASS) will be held on October 14 through
18, 2008, at the Metro Toronto Convention Centre in Toronto,
Ontario, Canada. Web site: www.spine.org
The thirty-sixth Annual Meeting of the Cervical Spine
Research Society (CSRS) will be held on December 4 through
6, 2008, at the Renaissance Austin Hotel in Austin, Texas. It will
be preceded by an Instructional Course sponsored by the
Cervical Spine Research Society, to be held on December 3,
2008, at the Renaissance Austin Hotel in Austin, Texas.
Web site: www.csrs.org
The Federation of Spine Associations will present the
spine program on Specialty Day at the Annual Meeting of the
American Academy of Orthopaedic Surgeons (AAOS), to be
held on Saturday, February 28, 2009, in Las Vegas, Nevada.
Web site: www.aaos.org
The Annual Meeting of The International Society for the
Study of the Lumbar Spine (ISSLS) will be held on May 4
through 8, 2009, in Miami, Florida. Web site: www.issls.org
The sixteenth Annual International Meeting on Ad-
vanced Spine Techniques (IMAST) will be held on July 15
through 18, 2009, in Vienna, Austria. Web site:
www.imastonline.com
The thirty-fifth Annual Meeting of the American Spinal
Injury Association (ASIA) and the United Spinal Association
(USA) will join forces in 2009 to present ‘‘Congress on Spinal
Cord Medicine and Rehabilitation.’’ The Congress will be held
on September 22 through 26, 2009, in Dallas, Texas. Web site:
www.asia-spinalinjury.org
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Aminmansour B, Khalili HA, Ahmadi J, Nourian M. Effect of high-dose
intravenous dexamethasone on postlumbar discectomy pain. Spine.
2006;31:2415-7.
Sixty-one patients undergoing lumbar discectomy were randomly as-
signed to receive 40 mg of dexamethasone intravenously, 80 mg of dexameth-
asone intravenously, or placebo following the skin incision. Based on a visual
analog pain scale one day after surgery, the mean radicular pain score was
decreased by 4.26 and 4.15 points in the two dexamethasone groups and by only
2.73 points in the control group (p = 0.006). The mean total morphine used was
lower in the 80-mg group than in the control group (p = 0.012). Thus, intra-
operative intravenous dexamethasone can reduce postoperative radicular pain
and narcotic usage in the first twenty-four hours after single-level discectomy.
Autio RA, Karppinen J, Niinima¨ki J, Ojala R, Veeger N, Korhonen T, Hurri
H, Tervonen O. The effect of infliximab, a monoclonal antibody against TNF-
alpha, on disc herniation resorption: a randomized controlled study. Spine.
2006;31:2641-5.
A report was generated with use of data from the FIRST II study
(Finnish Infliximab Related Study). In that randomized controlled study, in-
fliximab (a monoclonal antibody against tumor necrosis factor-alpha) was
compared with placebo for the treatment of disc-herniation-induced sciatica in
patients who were considered to be candidates for discectomy. Magnetic res-
onance imaging was performed for twenty-one patients at Weeks 0, 2, 12, and
26 following treatment. Eleven patients received a single infusion (5 mg/kg) of
infliximab, and ten received placebo. The authors found that the volume of the
herniated disc reduced in both groups over time, with no difference noted
between the groups. They concluded that infliximab does not interfere with
resorption of disc herniation.
Bernaards CM, Arie¨ns GA, Knol DL, Hildebrandt VH. The effectiveness of a
work style intervention and a lifestyle physical activity intervention on the
recovery from neck and upper limb symptoms in computer workers. Pain.
2007;132:142-53.
Bernaards et al. performed a randomized controlled study of the ef-
fectiveness of work style intervention and physical activity on recovery from
neck and upper extremity pain in computer workers. Four hundred and sixty-
eight patients were randomized into three groups: (1) the work style group, (2)
the work style and physical therapy group, and (3) the usual care group. The
results were conflicting. The patients in the work style alone group had better
relief of symptoms in comparison with those in the other two groups; however,
no difference was noted in terms of physical activities. Therefore, this study
showed the limited effectiveness of work style and exercise on recovery from
neck pain.
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Braun J, Zochling J, Baraliakos X, Alten R, Burmester G, Grasedyck K,
Brandt J, Haibel H, Hammer M, Krause A, Mielke F, Tony HP, Ebner W,
Go¨mo¨r B, Hermann J, Zeidler H, Beck E, Baumgaertner M, Sieper J. Efficacy
of sulfasalazine in patients with inflammatory back pain due to undifferenti-
ated spondyloarthritis and early ankylosing spondylitis: a multicentre rando-
mised controlled trial. Ann Rheum Dis. 2006;65:1147-53.
Patients with inflammatory back pain due to active undifferentiated
spondyloarthritis or ankylosing spondylitis were randomly assigned to twenty-
four weeks of treatment with sulfasalazine (2 g/day) or placebo. Peripheral
arthritis was present in 47% of the subjects. No noticeable difference in
treatment outcome was observed between the groups overall. However, in the
subset of patients with inflammatory back pain and no peripheral arthritis,
sulfasalazine was more effective than placebo.
Chow RT, Heller GZ, Barnsley L. The effect of 300 mW, 830 nm laser on
chronic neck pain: a double-blind, randomized, placebo-controlled study.
Pain. 2006;124:201-10.
Ninety subjects with chronic neck pain were randomized to receive a
course of fourteen treatments over seven weeks with either active or sham laser
to tender areas of the neck. The mean visual analog pain scores improved by 2.7
in the low-level laser treatment group and worsened by 0.3 in the control
group. There was no difference between the groups in terms of SF-36 scores.
The optimal design of this study suggests that this treatment warrants addi-
tional study.
Clarke JA, van Tulder MW, Blomberg SE, de Vet HC, van der Heijden GJ,
Bronfort G, Bouter LM. Traction for low-back pain with or without sciatica.
Cochrane Database Syst Rev. 2007;2:CD003010.
This systematic review of the literature was performed to determine the
effectiveness of traction as compared with sham, placebo, reference treatments,
or no treatments for patients with low back pain. The authors concluded that
traction as a single treatment is not likely to be effective for patients with acute,
subacute, and chronic low back pain and that traction cannot be judged as
effective for patients with sciatica on the basis of the currently available
evidence.
Djavid GE, Mehrdad R, Ghasemi M, Hasan-Zadeh H, Sotoodeh-Manesh A,
Pouryaghoub G. In chronic low back pain, low level laser therapy combined
with exercise is more beneficial than exercise alone in the long term: a ran-
domised trial. Aust J Physiother. 2007;53:155-60. Erratum in: Aust J Physiother.
2007;53:216.
Low-level laser therapy is thought to relieve musculoskeletal pain by
means of an anti-inflammatory effect, reduction of interstitial swelling, and
stimulation of ligament healing. In this study, the authors performed a ran-
domized controlled trial to compare low-level laser treatment, low-level laser
treatment combined with exercise, and placebo laser combined with exercise
for patients who had had isolated low back pain for twelve weeks. Laser
treatment combined with exercise had a small but significant benefit compared
with exercise or placebo only. The effect size was small, but the study did
provide justification for future investigation of low-level laser treatment.
Eisenberg DM, Post DE, Davis RB, Connelly MT, Legedza AT, Hrbek AL,
Prosser LA, Buring JE, Inui TS, Cherkin DC. Addition of choice of com-
plementary therapies to usual care for acute low back pain: a randomized
controlled trial. Spine. 2007;32:151-8.
In this prospective randomized study, the usual conservative treatment
of low back pain was compared with a treatment plan that gives patients with
back pain a choice of either acupuncture, chiropractic, or massage therapy in
addition to the usual treatment. The authors found that there was no difference
between the groups at five weeks in terms of symptoms and functional status.
The group of patients who had a choice in treatment had greater satisfaction
but also had an increased cost of treatment.
Ferreira ML, Ferreira PH, Latimer J, Herbert RD, Hodges PW, Jennings
MD, Maher CG, Refshauge KM. Comparison of general exercise, motor
control exercise and spinal manipulative therapy for chronic low back pain:
a randomized trial. Pain. 2007;131:31-7.
The authors performed a randomized controlled study comparing
general exercise, motor core control exercise of paraspinal muscles, and ma-
nipulative therapy in patients with chronic low back pain. The motor core
control exercise and manipulative therapy had a very small positive effect at
eight weeks, but there was no difference among the groups at six and twelve
months. Similar to the findings of other studies targeting specific muscle
groups or spinal regions, there does not appear to be a benefit over general
exercise in patients with chronic low back pain.
Hancock MJ, Maher CG, Latimer J, McLachlan AJ, Cooper CW, Day RO,
Spindler MF, McAuley JH. Assessment of diclofenac or spinal manipulative
therapy, or both, in addition to recommended first-line treatment for acute low
back pain: a randomised controlled trial. Lancet. 2007;370:1638-43.
Hancock et al. performed a randomized controlled study of patients
with acute low back pain to compare four different treatment groups: diclo-
fenac plus spinal manipulation, diclofenac plus placebo manipulation, spinal
manipulation plus placebo, and double placebo. No group experienced an
improved outcome compared with the others. Thus, it does not appear that
spinal manipulation or diclofenac resulted in faster recovery over placebo in
patients with acute low back pain.
Kumar K, Taylor RS, Jacques L, Eldabe S, Meglio M, Molet J, Thomson S,
O’Callaghan J, Eisenberg E, Milbouw G, Buchser E, Fortini G, Richardson J,
North RB. Spinal cord stimulation versus conventional medical management
for neuropathic pain: a multicentre randomised controlled trial in patients
with failed back surgery syndrome. Pain. 2007;132:179-88.
The effectiveness of spinal cord stimulation in patients with failed back
surgery syndrome who have ongoing neuropathic pain was assessed. One
hundred patients were randomized to spinal cord stimulation combined with
conventional medical management or conventional medical management
alone. At six months, 48% of patients who had been managed with spinal cord
stimulation achieved the goal of >50% pain reduction, compared with only 9%
of those who had received conventional management. The authors justifiably
concluded that in selected patients with failed back surgery syndrome, spinal
cord stimulation provides better pain relief and improved quality of life and
functional capacity compared with standard medical management.
Malmivaara A, Sla¨tis P, Helio¨vaara M, Sainio P, Kinnunen H, Kankare J,
Dalin-Hirvonen N, Seitsalo S, Herno A, Kortekangas P, Niinima¨ki T, Ro¨nty
H, Tallroth K, Turunen V, Knekt P, Ha¨rka¨nen T, Hurri H; Finnish Lumbar
Spinal Research Group. Surgical or nonoperative treatment for lumbar spinal
stenosis? A randomized controlled trial. Spine. 2007;32:1-8.
A randomized controlled trial that compared decompressive surgery
(n = 50) with conservative treatment (n = 44) for lumbar spinal stenosis with
follow-up at six, twelve, and twenty-four months was conducted. Both groups
demonstrated improvement in the Oswestry Disability Index, leg and back
pain, and walking ability. Patients undergoing surgery had greater improve-
ment in terms of leg and back pain as well as the Oswestry Disability Index.
This improvement diminished over time, but it was still significant at the time
of the two-year follow-up.
Parker MJ, Livingstone V, Clifton R, McKee A. Closed suction surgical
wound drainage after orthopaedic surgery. Cochrane Database Syst Rev.
2007;3:CD001825.
Parker et al. performed a systematic review with use of Cochrane
methodology on the effectiveness of closed suction drainage in orthopaedic
surgery. They included thirty-six studies with 5464 patients involving a
broad spectrum of orthopaedic procedures. No differences were noted be-
tween the groups managed with and without drainage. No differences in
adverse events such as wound infection, hematoma, dehiscence or reoper-
ations were present; however, blood transfusions were more common when
drains were used, and the need for dressing changes was more common when
drains were not used.
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Peul WC, van Houwelingen HC, van den Hout WB, Brand R, Eekhof JA,
Tans JT, Thomeer RT, Koes BW; Leiden-The Hague Spine Intervention
Prognostic Study Group. Surgery versus prolonged conservative treatment for
sciatica. N Engl J Med. 2007;356:2245-56.
In this prospective study, patients with severe sciatica were ran-
domized to either early surgery or prolonged conservative treatment. There
were no significant overall differences in disability scores during the first
year between patients assigned to early surgery and those assigned to
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Bryan cervical disc replacement. Patients were randomized to receive cervical
disc replacement or anterior cervical discectomy and fusion with allograft
and a plate. The Bryan group showed small but significantly greater im-
provement in the Neck Disability Index, neck and arm pain visual analog
scores, and the SF-36 physical component score. The two-year data from this
limited group of experienced surgeons are positive. The key questions that
remain to be answered are whether this success will persist in the hands of
less skilled surgeons, whether the small early advantages of Bryan disc re-
placement will persist at longer time points, and whether or not cervical disc
replacement will decrease the frequency of adjacent-level degeneration
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In this prospective randomized study, circumferential fusion was
compared with posterolateral fusion with instrumentation for the treatment of
chronic low back pain. At five to nine years of follow-up, the circumferential
fusion group showed significantly better improvement than the posterolateral
fusion group in terms of the selected outcome and low back pain scores. There
was no difference in the SF-36 mental health component or the leg pain score.
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This paper presents the as-treated analysis of the Spine Patient Out-
comes Research Trial (SPORT), a randomized trial comparing operative with
nonoperative treatment for lumbar disc herniation. Patients in both groups
showed improvement in clinical outcomes. At three months, patients in the
operative treatment group had greater improvement in clinical outcomes,
including bodily pain, physical function, and the Oswestry Disability Index.
These improvements, although still present and greater than in the nonoper-
ative treatment group, were diminished at the time of the two-year follow-up.
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This was a multicenter study of patients with symptomatic degenerative
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